Recent Posts
- Cue Biopharma and ImmunoScape Announce Strategic Collaboration to Develop Breakthrough Cell Therapy Approach for Solid Tumors
- Blood memory CD8 T cell phenotypes in lung cancer patients predict immune checkpoint treatment responses
- PIPLOM: prediction of exogenous peptide loading on major histocompatibility complex class I molecules
- ImmunoScape presents at the 24th BioEquity Europe 2024
- ImmunoScape at 5th Annual TCR-Based Therapies for Solid Tumors Summit
Archives
- November 2025
- September 2025
- March 2025
- May 2024
- April 2024
- March 2024
- December 2023
- October 2023
- June 2023
- May 2023
- December 2022
- October 2022
- September 2022
- August 2022
- June 2022
- May 2022
- March 2022
- September 2021
- July 2021
- May 2021
- March 2021
- February 2021
- January 2021
- November 2020
- October 2020
- September 2020
- July 2020
- June 2020
- April 2020
- February 2020
- November 2019
- October 2019
- September 2019
- April 2019
- February 2019
- January 2019
- December 2018
- November 2018
- October 2018
- June 2018
- May 2018
- April 2018
- February 2018
- November 2017
- October 2017
- September 2017
- July 2017
- May 2017
- April 2017
- March 2017
- January 2017
- August 2016
- July 2016
- April 2016
- January 2016
- June 2015
- October 2014
- January 2014
- June 2013
- January 2012
- July 2011
- June 2009
